Scantibodies Laboratory

Executive Summary

Scantibodies Laboratory is a privately held, full-service contract manufacturing organization (CMO) specializing in antibody production and diagnostic component manufacturing. Founded in 1976 and headquartered in Santee, California, the company offers a comprehensive suite of services including monoclonal and polyclonal antibody development, heterophilic blocking reagents, controls, plasma and serum products, lyophilization, formulation, cycle optimization, labeling, packaging, warehousing, fulfillment, and logistics. With nearly five decades of operational history, Scantibodies has established itself as a reliable partner for diagnostic companies seeking high-quality raw materials and custom manufacturing solutions. The company's integrated capabilities span the entire value chain from raw material production to finished product distribution, enabling clients to streamline their supply chains and accelerate time to market. Despite its long tenure, Scantibodies remains privately held and has not disclosed recent financial performance or growth metrics, limiting visibility into its market position relative to larger CMOs. However, its sustained presence suggests a loyal customer base and consistent demand for its specialized services. The diagnostics sector, driven by increasing focus on personalized medicine and point-of-care testing, presents continued opportunities for the company to leverage its antibody expertise and manufacturing flexibility.

Upcoming Catalysts (preview)

• Q4 2026Expansion of lyophilization capacity to meet growing diagnostic demand40% success
• H1 2027Strategic partnership with a major diagnostic OEM for monoclonal antibody supply30% success